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MaBACKGROUND Suspected genetic causes for extracellular matrix (ECM) dysregulation in the ascending aorta in
patients with bicuspid aortic valves (BAV) have inﬂuenced strategies and thresholds for surgical resection of BAV
aortopathy. Using 4-dimensional (4D) ﬂow cardiac magnetic resonance imaging (CMR), we have documented increased
regional wall shear stress (WSS) in the ascending aorta of BAV patients.
OBJECTIVES This study assessed the relationship between WSS and regional aortic tissue remodeling in BAV patients
to determine the inﬂuence of regional WSS on the expression of ECM dysregulation.
METHODS BAV patients (n ¼ 20) undergoing ascending aortic resection underwent pre-operative 4D ﬂow CMR to
regionally map WSS. Paired aortic wall samples (i.e., within-patient samples obtained from regions of elevated and
normal WSS) were collected and compared for medial elastin degeneration by histology and ECM regulation by protein
expression.
RESULTS Regions of increased WSS showed greater medial elastin degradation compared to adjacent areas
with normal WSS: decreased total elastin (p ¼ 0.01) with thinner ﬁbers (p ¼ 0.00007) that were farther apart
(p ¼ 0.001). Multiplex protein analyses of ECM regulatory molecules revealed an increase in transforming growth
factor b-1 (p ¼ 0.04), matrix metalloproteinase (MMP)-1 (p ¼ 0.03), MMP-2 (p ¼ 0.06), MMP-3 (p ¼ 0.02),
and tissue inhibitor of metalloproteinase-1 (p ¼ 0.04) in elevated WSS regions, indicating ECM dysregulation in
regions of high WSS.
CONCLUSIONS Regions of increased WSS correspond with ECM dysregulation and elastic ﬁber degeneration in the
ascending aorta of BAV patients, implicating valve-related hemodynamics as a contributing factor in the development of
aortopathy. Further study to validate the use of 4D ﬂow CMR as a noninvasive biomarker of disease progression and its
ability to individualize resection strategies is warranted. (J Am Coll Cardiol 2015;66:892–900) © 2015 by the American
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AB BR E V I A T I O N S
AND ACRONYM S
3D = 3-dimensional
4D = 4-dimensional
BAV = bicuspid aortic valve
CMR = cardiac magnetic
resonance imaging
ECM = extracellular matrix
IQR = interquartile range
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893B icuspid aortic valves (BAVs) are associatedwith an increased predisposition towardsdilation of the ascending aorta that could in-
crease the rates of aortic complications such as aortic
dissection, rupture, and/or sudden death (1,2).
Although several dilation patterns have been pro-
posed (2), considerable debate remains as to whether
they are due to an inherent aortic wall defect (i.e., ge-
netic aortopathy) or are secondary to valve-related
changes in regional hemodynamics and shear stressSEE PAGE 901
MMP = matrix
metalloproteinase
TGF = transforming growth
factor
TIMP = tissue inhibitor of
matrix metalloproteinase
WSS = wall shear stress(i.e., acquired etiology). A genetic etiology for BAV
aortopathy is widely accepted andmay prompt aggres-
sive resection strategies to remove diseased tissues at
risk of future complications (3,4). Increasingly, valve-
related hemodynamics are believed to contribute to
disease progression (5). Greater understanding of the
pathophysiology of BAV aortopathy may facilitate
improved surgical resection strategies, development
of best practices and effective clinical guidelines, and
in so doing, optimize clinical outcomes (6).
Flow-sensitive cardiac magnetic resonance imag-
ing (CMR) with full volumetric coverage of the
ascending aorta (4-dimensional [4D] ﬂow CMR) can
measure and visualize complex aortic 3-dimensional
(3D) blood ﬂow patterns, such as ﬂow jets, vortices,
and helical ﬂow. Using 4D ﬂow CMR, we previously
observed that normally functioning BAVs are associ-
ated with disturbed ﬂow patterns in the ascending
aorta, with regional increases in wall shear stress
(WSS) (7), a parameter known to be associated with
vessel wall remodeling (8). We further established
that the location of BAV cusp fusion is associated with
different patterns of ascending aorta dilation (9).
Recent studies have provided signiﬁcant associative
evidence that the pattern of cusp fusion corresponds
with the expression of aortopathy (10,11), thus
aligning with previous imaging ﬁndings implicating
altered outﬂow patterns and the regional expression
of elevated WSS with BAV morphology. To further
investigate these ﬁndings, in this study, we
measured aortic WSS by 4D ﬂow CMR in healthy
normal volunteers and BAV patients to detect non-
physiological values, and for the ﬁrst time, corre-
lated valve-related changes in WSS to regional tissue
architecture and remodeling in paired BAV aortic
wall tissue samples.
METHODS
With internal review board approval and informed
consent, 20 BAV patients referred for ascending
aortic surgery were enrolled. Patients with previousascending aortic surgery or evidence of other
forms of connective tissue disease were
excluded. Healthy age-matched controls
(n ¼ 10) with tricuspid aortic valves were
enrolled to compute regionally resolved
95% conﬁdence interval values for physio-
logically normal aortic WSS (12); these con-
trols had no evidence of cardiovascular
disease and did not undergo surgery. The
degree of aortic stenosis was graded based
on absolute systolic peak velocity by
continuous-wave Doppler ultrasound (mild: 2
to 3 m/s; moderate/severe: $3 m/s), and
aortic regurgitation was graded based on
regurgitant fraction (mild: <30%; moderate/
severe: $30%) (13).
Participants received pre-operative CMR
at 1.5-T or 3-T (Magnetom Aera, Espree, Avanto,
Skyra, Siemens Healthcare, Erlangen, Germany) to
assess presence and signiﬁcance of suspected BAV.
4D ﬂow CMR provided complete volumetric
coverage of the thoracic aorta for quantiﬁcation of
temporally resolved 3D blood ﬂow velocities. Data
were acquired during free breathing using respira-
tory and prospective electrocardiographic gating
(14), with imaging parameters as described previ-
ously (12). Velocity encoding ranged from 150 to
400 cm/s based on the severity of valve stenosis.
If the glomerular ﬁltration rate was >30 ml/min,
gadopentetate dimeglumine, gadofosveset triso-
dium, or gadobenate dimeglumine was administered
intravenously, and the ﬂip angle was set to 15;
otherwise, 7 was used. Patient-speciﬁc WSS heat
maps of the BAV aorta were computed relative to a
map of the population average for healthy age-
matched controls as described in detail previously
(12,15,16). WSS regions outside the healthy 95%
conﬁdence intervals were classiﬁed as abnor-
mal. Intra-aortic regions of normal, depressed, and
elevated WSS were mapped onto 3D visualizations
of patient-speciﬁc aortas (Figure 1).
Aortic wall samples were collected as permitted by
the extent of ascending aorta resection; surgeons
were blinded to WSS heat maps. Samples were
labeled according to pre-operative zonal designations
relative to the position of the right pulmonary artery
(zones 1, 2, and 3 correspond to regions proximal,
adjacent, and distal to the right pulmonary artery,
respectively) (Figure 1), and according to circumfer-
ential location (greater curvature, lesser curvature,
anterior or posterior wall). Tissue samples were
divided in 2 for histology and protein analysis, ﬂash-
frozen in optimal cutting temperature freezing com-
pound (VWR International, Radnor, Pennsylvania)
FIGURE 1 BAV Aortas: WSS Heat Maps and Elastin Fiber Staining
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Aortic wall (A, B, and C denote 3 different bicuspid aortic valve [BAV] aortas) from regions of high wall shear stress (WSS) (right panels;
closed circles) had fewer elastin ﬁbers (black) that were thinner and farther apart compared with regions with normal WSS (left panels;
open circles) in the same human aortas (40 magniﬁcation). Samples were collected from zone 1, 2, or 3, and from either the greater
curvature, lesser curvature, or anterior or posterior walls; accompanying diameters for tissue collection sites are shown. Grey denotes
normal WSS within the 95% conﬁdence interval compared with a healthy tricuspid aortic valve population; red and purple denote
elevated and depressed WSS, respectively. Insets show steady-state free precession images of the aortic valve and Sievers valve
phenotype. 3D ¼ 3-dimensional.
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894and liquid nitrogen within 15 min of resection, and
then stored at 80C until use. Paired samples of
each patient’s aorta from regions of normal and
elevated WSS were compared.
Tissue designated for histology was thawed,
sectioned circumferentially, and then ﬁxed in 10%
buffered neutral formalin (VWR International) for a
maximum of 1 week and parafﬁn-embedded. Sections
of 6 mm were mounted for Verhoeff-Van Gieson
staining of medial elastin ﬁbers. Chromatic analysis
of elastin abundance was performed (Aperio ePa-
thology, Leica Biosystems, Buffalo Grove, Illinois).
Total elastin content was computed as the meanpercent area of elastin staining relative to the total
area analyzed of 6 representative ﬁelds of view
(40 magniﬁcation) as selected by blinded observer.
Distance between intact elastin ﬁbers and their
thicknesses were measured (ImageScope Viewing
Software, Leica Biosystems) by blinded observer with
a mean value computed for each sample taken
from an average of 131 measurements per circum-
ferentially sectioned slide (as described by Bauer
et al. [17]).
Tissue designated for protein quantiﬁcation was
homogenized in 20 mmol/l Tris-HCl buffer (pH 7.5,
0.5% Tween 20, 150 mmol/l NaCl, and Roche
TABLE 1 Patient Characteristics in BAV Study Population
(N ¼ 20)
Age, yrs 48  15
Female 2 (10)
BAV classiﬁcation
Type 0, lateral 2 (10)
Type 1, RN 1 (5)
Type 1, RL 12 (60)
Type 2, RL/RN 5 (25)
Aortic diameter, cm
Sinus of Valsalva 4.4  0.5 (range 3.7–5.7)
Mid ascending aorta 4.7  0.6 (range 3.6–6.3)
Aortic valve function
No AS, moderate/severe AR 5 (25)
Mild AS, moderate/severe AR 1 (5)
Moderate/severe AS, no AR 5 (25)
Moderate/severe AS, mild AR 3 (15)
Moderate/severeAS,moderate/severeAR 6 (30)
Hypertension 7 (35)
Surgical procedure: aortic valve
Repair 1 (5)
Replacement 19 (95)
AVR 4 (20)
Bentall 14 (70)
Ross 1 (5)
Surgical procedure: AsAo
AsAo replacement 20 (100)
Root replacement 16 (80)
Hemi-arch 8 (40)
Values are mean  SD or n (%).
AR ¼ aortic regurgitation; AS ¼ aortic stenosis; AsAo ¼ ascending aorta; AVR ¼
aortic valve replacement; BAV ¼ bicuspid aortic valve; RL ¼ right–left coronary
cusp fusion; RN ¼ right coronary–noncoronary cusp fusion.
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895complete protease inhibitor 1:100) and centrifuged at
10,000 g for 10 min at 4C. Supernatant containing
1.0 mg of protein was assayed in duplicate for con-
centration of transforming growth factor (TGF)-b-1,
matrix metalloproteinases (MMPs), and tissue in-
hibitors of MMPs (TIMP) using the multiplex ﬂuores-
cent bead assay (Eve Technologies, Calgary, Alberta,
Canada).
STATISTICAL ANALYSIS. All group data are pre-
sented as mean  SD if normally distributed or
as median (interquartile range [IQR]) if non-
normally distributed. Normality was assessed using
the Shapiro-Wilk test. Normally and non-normally
distributed data were compared using a paired
Student t test or the Wilcoxon signed rank test,
respectively (both 2-tailed). Cohort-averages be-
tween 2 groups were compared using the Student
t test when normally distributed or the Mann-
Whitney test when non-normally distributed. Sta-
tistical analyses were performed using GraphPadPrism 6.0 (GraphPad Software, La Jolla, California),
with p < 0.05 considered statistically signiﬁcant.
RESULTS
Patient demographics are summarized in Table 1.
Healthy controls were used to deﬁne physiologically
normal WSS values and were age-matched to BAV
patients (50  14 years vs. 48  15 years, respectively;
p ¼ 0.83). BAV patients were predominantly male
with type 1 fusion of the right and left coronary
cusps. Surgery was primarily indicated for BAV
dysfunction; all patients had moderate/severe ste-
nosis or regurgitation. Mean aortic diameter was
4.4  0.5 cm at the sinus of Valsalva and 4.7  0.6 cm
for the ascending aorta. Most patients underwent
aortic valve replacement (1 patient underwent BAV
repair). All patients had ascending aortic resection,
with most requiring concomitant root replacement
and a few undergoing hemiarch resection using deep
hypothermic circulatory arrest. Tissue corresponding
to regions of normal and elevated WSS were primarily
collected from zone 2 of the BAV aorta and from the
anterior wall and greater curvature, respectively.
Samples collected from patients are summarized in
Online Table.
We quantiﬁed the total elastin content and
architecture by histology image analysis. Aortic wall
from regions of normal and elevated WSS demon-
strated signiﬁcantly decreased elastin content and
architecture consistent with aortopathy (Figures 1A
to 1C). Aortic wall exposed to elevated WSS
showed reduced elastin abundance compared with
aortic wall subjected to normal WSS within the same
aorta (p ¼ 0.01) (Figure 2A). Similarly, the cohort-
averaged percent area of elastin was signiﬁcantly
decreased in regions of elevated WSS among BAV
aortas (36.61  16.87% vs. 49.12  16.53%; p ¼ 0.04)
(Figure 2B). Compared with aortic wall subjected to
normal WSS, regions of elevated WSS had elastin
ﬁbers that were signiﬁcantly thinner among patient
pairs (p ¼ 0.00007) (Figure 2C). The absolute mean
thickness of elastin ﬁbers also was signiﬁcantly
decreased in regions of elevated WSS compared with
regions of normal WSS (2.72  0.40 mm vs. 3.25 
0.27 mm; p ¼ 0.00002) (Figure 2D). The median dis-
tance between elastin ﬁbers was signiﬁcantly greater
in regions of elevated WSS compared to normal
WSS (p ¼ 0.001) (Figure 2E). Similarly, cohort-
averaged median distance between elastin ﬁbers
was signiﬁcantly increased in aortic wall subjected
to elevated WSS (28.34 mm [IQR: 22.03 to 36.32 mm]
vs. 20.39 mm [IQR: 18.35 to 24.43 mm]; p ¼ 0.01)
(Figure 2F).
FIGURE 2 Metrics of Elastin Fiber Architecture
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Elastin ﬁber characteristics from Verhoeff-Van Gieson elastin staining for patient pairs
(A, C, and E) and cumulative group means (B, D, and F) for aortic wall subjected to normal
and elevated WSS are shown. Total percent area of elastin staining was decreased in
regions of elevated WSS compared to normal WSS (A and B), and remaining ﬁbers were
thinner (C and D). Greater distances between intact adjacent elastin ﬁbers were observed
in regions of elevated WSS (E and F). Abbreviations as in Figure 1.
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896Regions of elevated WSS had signiﬁcantly higher
concentrations of TGFb-1 protein (p ¼ 0.04) (Figure 3)
compared with paired regions of normal WSS in the
same aortas.
Aortic wall subjected to normal and elevated WSS
within each patient’s aorta were proﬁled for MMP and
TIMP protein concentrations (Table 2). The absolute
levels of MMP and TIMP protein expression in the
samples were highly variable. MMP-2 and TIMP-2
were the most highly expressed MMP and TIMP in
the aorta. Compared with regions of normal WSS,
aortic wall exposed to elevated WSS demonstrated
signiﬁcantly increased relative concentrations of
MMP-1 (p ¼ 0.03), MMP-3 (p ¼ 0.02), and TIMP-1
(p ¼ 0.04), and there was a trend (p ¼ 0.06) for
increased concentrations of MMP-2.
DISCUSSION
BAV is an inheritable disorder, and a genetic theory
for the associated aortopathy is widely held, positing
that the aorta has an inherent genetic weakness and
is prone to dilation and rupture from an underlying
dysregulation of extracellular matrix (ECM) in the
aortic medial layer (1,5). This perspective has en-
couraged more aggressive approaches towards aortic
resection using strategies similar to those applied in
patients with proven genetic aortopathies, such as
Marfan syndrome. Recently, we and others have
shown that valve-related hemodynamics may play
an important role in disease progression, where
altered ﬂow in the aorta is consistent with patterns
of aortic dilation (9–11,18,19). Recognizing that he-
modynamics may be altered in different regions of
the ascending aorta, regional differences have been
documented in key ECM proteins and cell pheno-
typic expressions, focused primarily on the con-
vexity versus the concavity of the BAV aorta (20,21).
These translational tissue studies suggest that
valve-related hemodynamics may inﬂuence disease
progression.
There is mounting evidence that both theories
may coexist (5,22). Valve-related hemodynamics may
exacerbate disease progression in genetically sus-
ceptible aortas (6). Given the absence of data showing
a mechanistic link between cusp fusion patterns,
altered aortic ﬂow, and expression of disease, con-
siderable debate surrounds the role of hemodynamics
in mediating BAV aortopathy (5). Recently, using 4D
ﬂow CMR, we observed that even normally func-
tioning BAVs are associated with disturbed ascending
aortic ﬂow and regional WSS increases, beyond
the hemodynamic derangements accounted for by
measures of stenosis and regurgitation (7). We further
FIGURE 3 TGFb-1 Concentrations in Regions of
Normal and Elevated WSS
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Absolute transforming growth factor b-1 (TGFb-1) concentrations
were greater in aortic wall regions of elevated compared with
normal wall sheer stress (WSS). Solid lines denote group means,
and p value represents analysis between paired patient samples
(normal and elevated WSS).
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897established that the location of BAV cusp fusion
was associated with different patterns of ascending
aortic dilation (9), suggesting that valve-related
hemodynamics may inﬂuence the expression of BAV
aortopathy.
Despite well-documented changes of WSS in BAV
patients, its role in the underlying aortopathy is un-
clear. In the current study, distinct regions of
increased WSS were uniformly observed in BAV pa-
tients despite varied cusp fusion patterns and types
or degrees of valve dysfunction. The signiﬁcant rela-
tionship between WSS derived from 4D ﬂow CMR and
regional aortic tissue remodeling provides evidence,
for the ﬁrst time, of the role of valve-related hemo-
dynamics in BAV aortopathy (Central Illustration).
WSS CORRESPONDS TO CHANGES RELATED TO
AORTOPATHY. To validate the inﬂuence of regional
WSS on tissue remodeling, we compared the medial
matrix architecture between areas of high and normal
WSS within each BAV aorta. This analysis is advan-
tageous because each patient serves as his or her
own control. Degeneration of the aortic media, par-
ticularly its elastic laminae, is the sine qua non ofBAV aortopathy, with a hallmark of elastic ﬁber
fragmentation (23). Bauer et al. (17) also observed
medial elastin degeneration characteristic of BAV
aortopathy, documenting thinner elastic laminae and
increased distances between laminae. In patients
with BAV stenosis undergoing aortic valve replace-
ment, Girdauskas et al. (24) documented qualitative
differences in aortic histology at the level of
aortotomy with different systolic transvalvular ﬂow
patterns.
We observed disrupted medial elastin ﬁber archi-
tecture in the aortic wall of our patient cohort,
consistent with BAV aortopathy, coupled with the
novel ﬁnding that elastin ﬁber fragmentation
and architectural derangement was signiﬁcantly
increased in areas of high versus normal WSS within
the same aortas. Areas of normal WSS also had evi-
dence of medial matrix degradation consistent with
BAV aortopathy, although less severe than corre-
sponding areas of high WSS. Given that histological
abnormalities are diffuse within the BAV aorta and
our study population had relatively mild levels of
aortic dilation (most <5.0 cm), the increased elastin
degradation observed in the areas of high WSS rela-
tive to adjacent areas with normal WSS is a striking
observation that provides strong evidence impli-
cating valve-related hemodynamics in medial matrix
degradation in BAV aortopathy.
TGFb is strongly implicated in the mechano-
transduction of WSS upstream of ﬂow-induced vas-
cular remodeling (25). In animal models of human
aortopathy, TGFb signaling is implicated in vascular
disease and progression as a critical mediator of
aortopathy (26). Forte and colleagues (20) showed
that TGFb and TGFb receptor-2 are increased in BAV
aorta, suggesting a role for TGFb in mediating dis-
ease. In this study, we provide novel data linking
aortic TGFb protein expression to local increases in
WSS, with ascending aortic TGFb concentration
signiﬁcantly elevated in regions of high aortic WSS
compared with adjacent regions with normal WSS.
These data strongly implicate WSS as contributing
to TGFb expression in the BAV aorta.
MMPs can directly degrade elastic ECM compo-
nents. Supporting a mechanistic role for valve-related
hemodynamics in MMP expression, Ikonomidis et al.
(27) showed altered MMP proﬁles stratiﬁed by
cusp fusion pattern in the BAV aorta. Although
many MMPs are expressed in the aorta, MMP-2 is
highly implicated in aortic aneurysms and elastic ma-
trix degeneration of remodeled arteries (28). Animal
models provide proof of concept for WSS as a trigger
for aortic wall MMP activation. For example, ﬂow-
mediated induction of MMP-2 expression was
TABLE 2 Absolute MMP and TIMP Concentrations in BAV Aortas
Median
Concentration
(pg/ml)
IQR
(pg/ml)
Range
(pg/ml) p Value
MMP-1*
Elevated WSS 11.04 5.8–20.5 2.4–148.2 0.027
Normal WSS 8.84 3.5–14.7 1.3–19.3
MMP-2
Elevated WSS 8,093.00 5,062.0–13,691.0 293.3–185,897.0 0.064
Normal WSS 6,060.00 2,621.0–12,910.0 197.1–119,902.0
MMP-3
Elevated WSS 85.28 51.6–162.8 29.2–485.1 0.019
Normal WSS 58.46 43.4–115.9 6.8–363.8
MMP-7*
Elevated WSS 75.3† 54.2‡ 8.5–165.6 0.653
Normal WSS 69.3† 72.7‡ 0.0–235.3
MMP-8
Elevated WSS 2,596.0 778.4–6,258.0 22.4–22,744.0 0.294
Normal WSS 3,594.0 1,754.0–7,706.0 404.5–37,267.0
MMP-9
Elevated WSS 4,806.0 2,377.0–19,356.0 479.6–74,046.0 0.596
Normal WSS 6,581.0 3,582.0–11,796.0 1,588.0–12,6759.0
MMP-10*
Elevated WSS 14.2 7.2–17.7 1.8–45.9 0.229
Normal WSS 10.5 8.1–13.1 0.7–36.1
TIMP-1
Elevated WSS 21,442.0 11,499.0–
36,679.0
4,022.0–151,540.0 0.040
Normal WSS 14,546.0 8,485.0–19,629.0 4,136.0–14,9919.0
TIMP-2
Elevated WSS 24,931.0 15,476.0–48,537.0 1,0399.0–
171,363.0
0.756
Normal WSS 21,721.0 14,892.0–
40,513.0
6,384.0–
336,986.0
TIMP-3
Elevated WSS 4,138.0† 2,991.0‡ 0.0–11,961.0 0.079
Normal WSS 3,272.0† 2,794.0‡ 0.0–9,862.0
TIMP-4
Elevated WSS 92.2 47.9–148.0 14.7–1,173.0 0.165
Normal WSS 79.0 57.7–128.9 1.9–840.1
*Number of samples outside range of detection: MMP-1 ¼ 7, MMP-7 ¼ 10, and MMP-10 ¼ 2. Concentrations are
reported as median [IQR] when nonnormally distributed or mean (†)  SD (‡) when normally distributed. p Values
denote paired analyses between regions of normal and elevated WSS in each BAV aorta.
IQR ¼ interquartile range; MMP ¼ matrix metalloproteinase; TIMP ¼ tissue inhibitor of matrix metal-
loproteinase; WSS ¼ wall shear stress; other abbreviations as in Table 1.
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898demonstrated in rabbit carotid arteries in association
with medial matrix degeneration and vessel dilation
(29). Furthermore, Atkins et al. (30) modeled BAV-
related elevated WSS in an ex vivo porcine aorta
system, and found increased MMP-2 expression and
activity. We previously reported evidence of MMP-2
elevations in the BAV aorta (31). The cumulative
evidence by meta-analysis of all such studies con-
ﬁrms that MMP-2 is consistently elevated in human
BAV aortopathy (32).
In the current study, we observed that aortic wall
MMP-2 was the most highly expressed MMP in theBAV aorta, with a trend (p ¼ 0.06) for greater
expression in areas of high WSS as compared to
adjacent areas with normal WSS in the same pa-
tients, and with signiﬁcant increases in MMP-3 in
the same areas. Importantly, the elevated levels of
MMP-2, MMP-3, and TGFb areas of increased WSS
were associated with fragmented medial elastin
ﬁbers. This observation also strongly implicates WSS
in mediating BAV aortic disease progression. In
addition to a direct role in degrading elastic tissue,
it is noteworthy that MMP-2 and MMP-3 can acti-
vate latent TGFb and increase its activity. These
factors may work synergistically to induce medial
matrix remodeling.
The observed TIMP changes are complex, and the
substantial variability between patients and regions
studied suggests that the regulatory control of TIMP
expression is less inﬂuenced by WSS than speciﬁc
MMPs and TGFb. TIMP-1 levels were increased in
areas of high WSS, but no signiﬁcant difference
was observed between groups with respect to other
TIMP species. The lack of increased compensatory
TIMP-2 expression in areas of high WSS may result
in heightened MMP-2 activity. Further study is
required to better deﬁne and understand the inﬂu-
ence of speciﬁc MMPs and TIMPs in BAV aortopathy
and their expression and activities with respect to
valve-related hemodynamics.
STUDY LIMITATIONS. In our study, 4D ﬂow CMR
was used as a research tool to obtain WSS maps in
individual patient aortas to better understand
whether blood ﬂow patterns play a role in the
expression of BAV aortopathy. Given the spatial and
temporal resolution of 4D ﬂow CMR, underestima-
tion of WSS is known to occur (7); however, relative
WSS values (i.e., high/low WSS) are retained be-
tween subjects when consistent imaging parameters
are employed. Here, we used similar parameters to
those of a prior study that demonstrated the
robustness of WSS measurements (33). Additionally,
same-patient samples ensured that the relative
WSS measurements were obtained in the same
subject and same exam. Therefore, resolution was
not deemed a signiﬁcant factor for the study pro-
tocol to detect elevated WSS. Although the con-
centrations of speciﬁc proteins of interest were
examined, further studies should investigate TGFb
and MMP-2 activities and other associated factors
such as shifts in cell phenotype that may also
mediate matrix remodeling. Additional comparison
to patients with tricuspid valves and dilated aortas
with areas of increased WSS should also be
explored.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Measurements
made using 4D ﬂow CMR suggest that valve-related hemody-
namics contribute to the development of aortopathy in patients
with BAV.
TRANSLATIONAL OUTLOOK: Validation studies are needed
to conﬁrm the utility of 4D ﬂow CMR as a noninvasive marker of
disease progression, predictor of aortic dissection or rupture, and
guide to the extent of surgical resection based on detailed
measurements of regional aortic wall shear stress.
CENTRAL ILLUSTRATION 4D Flow CMR and BAV Aortopathy
Guzzardi, D.G. et al. J Am Coll Cardiol. 2015; 66(8):892–900.
Using 4-dimensional ﬂow cardiac magnetic resonance imaging (4D ﬂow CMR), we assessed the relation between wall shear stress (WSS) and regional aortic tissue
remodeling in bicuspid aortic valve (BAV) patients. Elevated aortic WSS generated by aberrant ﬂow from cusp fusion corresponded to more severe extracellular
matrix (ECM) dysregulation than adjacent regions of normal WSS in the same patient’s aorta. Characteristic medial degeneration was observed throughout the aorta,
but elastic ﬁber degeneration was more severe in regions of elevated WSS (less elastin, thinner ﬁbers, and greater distances between laminae), where higher
concentrations of mediators of ECM dysregulation (matrix metalloproteinase [MMP] and transforming growth factor b [TGFb]) are also observed. These data implicate
valve-related hemodynamics as a contributing factor to BAV aortopathy.
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899CONCLUSIONS
Regions of increased WSS correspond with ECM dys-
regulation and elastic ﬁber degeneration in the
ascending aorta of BAV patients, implicating valve-
related hemodynamics as a mediator of aortopathy.
WSS as assessed by 4D ﬂow CMR may serve as a
noninvasive biomarker of regional aortic disease in
patients with BAV aortopathy (deemed sufﬁciently
severe to warrant operative intervention). Its utility
in prediction of disease progression, particularly in
earlier and less severe BAV aortopathy, awaits careful
study, as does the efﬁcacy of a targeted surgical
approach incorporating regional aortic WSS.
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